News
Home/ News
(Filtering posts by category: Patents) - Remove filter
If your business exports pharmaceutical products to Malaysia, licenses technology there, or is watching the region for growth opportunities, a regulatory change currently taking shape in Kuala Lumpur is worth your attention.
“Patent pending” does not mean a patent has been granted. However, a well-drafted pending patent application can still have real commercial value. It can create uncertainty for competitors, support investor confidence and help a business protect its position before the patent is granted.
Artificial intelligence is no longer a future concept in the pharmaceutical sector. It is already reshaping how new drugs are discovered, designed, tested and manufactured — and that shift is creating major opportunities for businesses working in life sciences, biotech and medical innovation.
The World Intellectual Property Report 2026 has a simple message: technology is spreading faster than ever — and the advantage now goes to the businesses that can adopt, adapt, and protect faster than their competitors.
The Federal Court has granted AstraZeneca an interlocutory injunction restraining Pharmacor Pty Ltd from launching generic versions of the diabetes medication dapagliflozin. Justice Downes delivered judgment on 16 February 2026, finding in favour of AstraZeneca despite Pharmacor's challenges to the patent's validity and the broader public interest in lower-cost generic medications.
If you’re thinking about patenting an idea, here’s the blunt truth upfront: only genuinely new ideas can be patented. That’s why one of the smartest things you can do before spending serious time or money is to check how others have already solved the same problem.
Australian businesses looking to protect inventions in Europe will soon have a more efficient and cost-effective pathway.
At the start of a new year, many businesses reassess their brands, products and IP portfolios. New launches, market entries and clean-ups are common. What’s often overlooked is the risk sitting in IP that appears abandoned.
For years, Australian innovators have faced uncertainty over whether computer-implemented inventions — software-based systems, digital platforms, or automated processes — can actually be patented. Now, a new Full Court decision has finally brought some clarity — and good news for software and technology businesses.
